Ezra Vadai

4.5k total citations · 2 hit papers
44 papers, 3.5k citations indexed

About

Ezra Vadai is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Ezra Vadai has authored 44 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Immunology, 24 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Ezra Vadai's work include Immunotherapy and Immune Responses (28 papers), Immune Cell Function and Interaction (11 papers) and vaccines and immunoinformatics approaches (9 papers). Ezra Vadai is often cited by papers focused on Immunotherapy and Immune Responses (28 papers), Immune Cell Function and Interaction (11 papers) and vaccines and immunoinformatics approaches (9 papers). Ezra Vadai collaborates with scholars based in Israel, United States and France. Ezra Vadai's co-authors include Valery Krizhanovsky, Lea Eisenbach, Yossi Ovadya, Anat Biran, Reut Yosef, Esther Tzehoval, Noam Pilpel, Michaël Feldman, Hilah Gal and Reba Condiotti and has published in prestigious journals such as Nature, Nature Medicine and Nature Communications.

In The Last Decade

Ezra Vadai

43 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Directed elimination of senescent cells by inhibition of BCL-W and BCL-XL

2016 717 citations Reut Yosef, Noam Pilpel et al. Nature Communications profile →
Impaired immune surveillance accelerates accumulation of senescent cells and aging

2018 397 citations Yossi Ovadya, Tomer Landsberger et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ezra Vadai Israel	23	1.6k	1.5k	1.2k	716	297	44	3.5k
Eric Campeau United States	17	2.2k 1.4×	705 0.5×	1.2k 1.0×	558 0.8×	438 1.5×	32	3.6k
Albert R. Davalos United States	20	2.3k 1.5×	1.0k 0.7×	2.0k 1.7×	636 0.9×	623 2.1×	27	4.3k
Denise P. Muñoz United States	9	1.5k 1.0×	670 0.5×	1.2k 1.0×	427 0.6×	312 1.1×	15	2.7k
Soyoung Lee Germany	17	2.0k 1.3×	578 0.4×	1.3k 1.1×	887 1.2×	436 1.5×	33	3.2k
Marzia Fumagalli Italy	12	2.7k 1.7×	849 0.6×	2.1k 1.8×	998 1.4×	611 2.1×	16	4.4k
Peggie Cheung United States	22	2.9k 1.8×	506 0.3×	1.3k 1.1×	485 0.7×	248 0.8×	27	4.3k
Olga Chernova United States	27	2.2k 1.4×	546 0.4×	635 0.5×	1.1k 1.6×	565 1.9×	42	3.7k
Jessica E. Bolden Australia	14	3.7k 2.4×	841 0.6×	806 0.7×	1.2k 1.6×	448 1.5×	17	4.9k
Ana O’Loghlen United Kingdom	19	1.6k 1.0×	771 0.5×	1.1k 0.9×	357 0.5×	502 1.7×	29	2.8k
Katherine A. Gollahon United States	26	1.4k 0.9×	584 0.4×	589 0.5×	329 0.5×	361 1.2×	41	2.7k

Countries citing papers authored by Ezra Vadai

Since Specialization

Citations

This map shows the geographic impact of Ezra Vadai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ezra Vadai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ezra Vadai more than expected).

Fields of papers citing papers by Ezra Vadai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ezra Vadai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ezra Vadai. The network helps show where Ezra Vadai may publish in the future.

Co-authorship network of co-authors of Ezra Vadai

This figure shows the co-authorship network connecting the top 25 collaborators of Ezra Vadai. A scholar is included among the top collaborators of Ezra Vadai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ezra Vadai. Ezra Vadai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sagiv, Adi, Amir Bar‐Shai, Yossi Ovadya, et al.. (2018). p53 in Bronchial Club Cells Facilitates Chronic Lung Inflammation by Promoting Senescence. Cell Reports. 22(13). 3468–3479. 41 indexed citations

Ovadya, Yossi, Tomer Landsberger, Hanna Leins, et al.. (2018). Impaired immune surveillance accelerates accumulation of senescent cells and aging. Nature Communications. 9(1). 5435–5435. 397 indexed citations breakdown →

Yosef, Reut, Noam Pilpel, Hilah Gal, et al.. (2017). p21 maintains senescent cell viability under persistent DNA damage response by restraining JNK and caspase signaling. The EMBO Journal. 36(15). 2280–2295. 214 indexed citations

Biran, Anat, Paula Abou Karam, Ezra Vadai, et al.. (2017). Quantitative identification of senescent cells in aging and disease. Aging Cell. 16(4). 661–671. 287 indexed citations

Yosef, Reut, Noam Pilpel, Ronit Tokarsky-Amiel, et al.. (2016). Directed elimination of senescent cells by inhibition of BCL-W and BCL-XL. Nature Communications. 7(1). 11190–11190. 717 indexed citations breakdown →

Sagiv, Adi, Dominick G. A. Burton, Ezra Vadai, et al.. (2016). NKG2D ligands mediate immunosurveillance of senescent cells. Aging. 8(2). 328–344. 252 indexed citations

Cafri, Gal, Esther Tzehoval, Zoya Alteber, et al.. (2015). mRNA-transfected Dendritic Cells Expressing Polypeptides That Link MHC-I Presentation to Constitutive TLR4 Activation Confer Tumor Immunity. Molecular Therapy. 23(8). 1391–1400. 15 indexed citations

Alteber, Zoya, et al.. (2014). Cryoimmunotherapy with local co-administration of ex vivo generated dendritic cells and CpG-ODN immune adjuvant, elicits a specific antitumor immunity. Cancer Immunology Immunotherapy. 63(4). 369–380. 24 indexed citations

Goldberger, Ofir, Ilan Volovitz, Arthur Machlenkin, et al.. (2008). Exuberated Numbers of Tumor-Specific T Cells Result in Tumor Escape. Cancer Research. 68(9). 3450–3457. 28 indexed citations

10.

Machlenkin, Arthur, Ronit Rosenfeld, Ilan Volovitz, et al.. (2006). Preventive and therapeutic vaccination with PAP-3, a novel human prostate cancer peptide, inhibits carcinoma development in HLA transgenic mice. Cancer Immunology Immunotherapy. 56(2). 217–226. 16 indexed citations

11.

Machlenkin, Arthur, Adrian Paz, Ofir Goldberger, et al.. (2005). Human CTL Epitopes Prostatic Acid Phosphatase-3 and Six-Transmembrane Epithelial Antigen of Prostate-3 as Candidates for Prostate Cancer Immunotherapy. Cancer Research. 65(14). 6435–6442. 64 indexed citations

12.

Lee, Sung‐Hyung, Erez Bar‐Haim, Arthur Machlenkin, et al.. (2004). In vivo rejection of tumor cells dependent on CD8 cells that kill independently of perforin and FasL. Cancer Gene Therapy. 11(3). 237–248. 19 indexed citations

13.

Lee, Sung‐Hyung, Erez Bar‐Haim, Ofir Goldberger, et al.. (2003). Expression of FasL by tumor cells does not abrogate anti-tumor CTL function. Immunology Letters. 91(2-3). 119–126. 4 indexed citations

14.

Marikovsky, Moshe, et al.. (2001). Cu/Zn superoxide dismutase plays a role in angiogenesis. International Journal of Cancer. 97(1). 34–41. 91 indexed citations

15.

Tirosh, Boaz, Mati Fridkin, Esther Tzehoval, et al.. (2000). Antigenicity and Immunogenicity of an Intracellular Delivery System of Major Histocompatibility Complex Class I Epitopes That Bypasses Proteasome Processing. Journal of Immunotherapy. 23(6). 622–630. 1 indexed citations

16.

Vadai, Ezra, et al.. (1997). Tuftsin–THF-γ2 chimeric peptides: potential novel immunomodulators. Immunopharmacology. 37(1). 43–52. 5 indexed citations

17.

Mandelboim, Ofer, Erez Bar‐Haim, Ezra Vadai, Mati Fridkin, & Lea Eisenbach. (1997). Identification of shared tumor-associated antigen peptides between two spontaneous lung carcinomas. The Journal of Immunology. 159(12). 6030–6036. 22 indexed citations

18.

Fitzer‐Attas, Cheryl, Myoung‐Sool Do, Sara W. Feigelson, et al.. (1997). Modification of PDGFα receptor expression or function alters the metastatic phenotype of 3LL cells. Oncogene. 15(13). 1545–1554. 8 indexed citations

19.

Mandelboim, Ofer, Ezra Vadai, Mati Fridkin, et al.. (1995). Regression of established murine carcinoma metastases following vaccination with tumour-associated antigen peptides. Nature Medicine. 1(11). 1179–1183. 129 indexed citations

20.

Plaksin, Daniel, Angel Porgador, Ezra Vadai, et al.. (1994). Effective anti‐metastatic melanoma vaccination with tumor cells transfected with MHC genes and/or infected with newcastle disease virus (NDV). International Journal of Cancer. 59(6). 796–801. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact